Insider filing · BMEZ

Boaz Weinstein bought $1.0M of BlackRock Health Sciences Term (BMEZ)

Executed Oct 15 2024, disclosed Oct 17 2024, 2 days later.

Over the 21 trading sessions from the disclosed entry session (Oct 17 2024), the stock returned -2.2% (delay-adjusted); from the execution session (Oct 15 2024), +0.8%. Derived: entry at the session's open, exit at the close 20 sessions later.

BW Boaz Weinstein 10% owner profile →

Boaz Weinstein (10% owner) filed 253 Form 4 reports in the past 24 months (107 purchases, 146 sales, 5 filed past the two-business-day deadline), most often in BlackRock Capital Allocation Term Trust (BCAT). Across 30 priced purchase filings, the average 21-session return was +3.7% from execution and +2.7% from disclosure (delay-adjusted; derived). The largest single filing was $20.2M of PDX (731,721 sh × $27.60, as filed), executed Jan 13 2025.

BMEZ BMEZ BMEZ · 7 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→